Tini Paolo, Nardone Valerio, Pastina Pierpaolo, Battaglia Giuseppe, Vinciguerra Claudia, Carfagno Tommaso, Rubino Giovanni, Carbone Salvatore Francesco, Sebaste Lucio, Cerase Alfonso, Federico Antonio, Pirtoli Luigi
IstitutoToscanoTumori, Florence, Italy.
Unit of Radiation Oncology, University Hospital of Siena, Policlinico S. Maria Alle Scotte, Viale Bracci, 53100, Siena, Italy.
Neurol Sci. 2017 Jun;38(6):975-982. doi: 10.1007/s10072-017-2876-y. Epub 2017 Mar 4.
Radiosurgery (SRS) is widely used in the treatment of brain oligo-metastases from NSCLC. The aim of present study is to evaluate the extent of perilesional edema in brain metastases as predictive factor of treatment response. This single center retrospective study included 42 consecutive patients (January 2011-December 2014) with 1-2 brain metastasis from NSCLC treated with Radiosurgery (SRS). Extent of perilesional edema was measured as maximal extension from the edge of lesion and classified as minor (<10 mm) or major (≥10 mm). We analyzed Modality of Brain Recurrence (MBR), classified as in-field or out-of- field, and Brain Progression Free-Survival (BPFS) after treatment stratified according to extent of perilesional edema. Analyzing modality of brain recurrence and BPFS, after a median follow-up of 6 months, we found that patients with minor edema had a better radiological response to SRS with none in-field recurrences and a lower risk of the onset of new brain lesions (out-of-field recurrence). Instead, patients group with major edema had a worse response rate of lesions treated, further, a higher risk of out-of-field brain relapse. Extent of perilesional edema in brain metastasis from NSCLC could be a predictive factor of response and brain progression after SRS treatment alone.
立体定向放射治疗(SRS)广泛应用于非小细胞肺癌脑寡转移瘤的治疗。本研究旨在评估脑转移瘤周围水肿程度作为治疗反应预测因素的情况。这项单中心回顾性研究纳入了42例连续患者(2011年1月至2014年12月),这些患者均为非小细胞肺癌脑转移1 - 2处且接受了立体定向放射治疗(SRS)。瘤周水肿程度通过测量距病变边缘的最大延伸范围来确定,并分为轻度(<10毫米)或重度(≥10毫米)。我们分析了脑复发模式(MBR),分为野内或野外复发,并根据瘤周水肿程度对治疗后的脑无进展生存期(BPFS)进行分层分析。在中位随访6个月后,分析脑复发模式和BPFS发现,轻度水肿患者对SRS的放射学反应更好,无野内复发,新发脑病变(野外复发)风险更低。相反,重度水肿患者组的病变治疗反应率较差,此外,野外脑复发风险更高。非小细胞肺癌脑转移瘤的瘤周水肿程度可能是单纯SRS治疗后反应和脑进展的预测因素。